See the latest news and media coverage for Organon. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global healthcare company focused on women's health
organon.comLast updated
In short: Organon agreed to be acquired by Sun Pharmaceutical Industries in an $11.75 billion transaction that received shareholder approval.
All healthcare providers who dispense or administer NEXPLANON must become certified, including previous Clinical Training Program completers, to mitigate complications from improper insertion and removal.
Pooled Phase 3 data showed early, consistent improvements across pediatric age groups and adults, as early as week 2.
The hormone-free copper IUD expands Organon's contraception portfolio and is FDA-approved for up to three years.
The approval is for a dysmenorrhea product, enhancing access and recognition of menstrual pain as an undertreated women's health issue, and credits Organon Japan's collaborative efforts.
In June of 2026, Organon completed its agreement to exclusively license global rights to Sebela’s MIUDELLA. MIUDELLA is a hormone-free, copper intrauterine device (IUD) indicated...
Sun Pharma receives investment-grade ratings from Moody's and S&P for its $11.75 billion acquisition of Organon & Co.
Sun Pharmaceutical Industries reported consolidated revenue growth of 10.1% year-on-year in the first quarter of FY27, driven ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage...
Track Organon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Organon and other trending companies.